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Iron deficiency anemia is a common condition in patients presenting for surgery, but despite its 
negative health impacts, the condition remains frequently unmanaged. Optimizing the patient’s 
own red cell mass should be addressed in the preoperative period. Intravenous iron has been 
advocated as an effective treatment modality.  
Objectives 
The objective of this systematic review was to critically appraise and synthesize the best 
available evidence related to the effectiveness and economic aspects of intravenous iron 
administration on the correction of iron deficiency anemia in the preoperative period. 
Inclusion criteria 
Types of participants 
Adult patients 18 years of age and older receiving intravenous iron compared with those taking 
iron orally, and those who were not on iron or were transfused with red blood cells for the 
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correction of anemia. Studies assessing the economic aspects of anemia management were 
also considered. 
Types of intervention(s)/phenomena of interest 
The quantitative component of the review considered studies that evaluated the management of 
anemia with iron infusions compared to oral iron treatment alone, oral iron in combination with 
erythropoietin, erythropoietin alone or hemoglobin correction with blood transfusion.  
The economic component of this review considered studies that evaluated the costs and 
benefits of iron infusions compared to oral iron treatment or hemoglobin correction with blood 
transfusion for the treatment of preoperative anemia. 
Types of studies 
The quantitative component of the review considered any experimental study design including 
randomized controlled trials (RCTs), non-RCTs and quasi-experimental studies for inclusion. 
The economic component of the review considered cost effectiveness, cost utility and cost 
benefit studies for inclusion. 
Types of outcomes 
The quantitative component of this review considered studies that reported on the impact of 
intravenous iron administration on: hemoglobin levels, red blood cell transfusion, length of stay 
in hospital, rate of readmission within 30 days of discharge, incidence of transfusion-related 
complications and changes in functional outcomes. 
The economic component of the review focused on cost benefits resulting from intravenous iron 
administration. 
Search strategy 
The search strategy aimed to find both published and unpublished studies. A three-step search 
strategy was utilized in this review. Studies published in English, German, Italian and Dutch 
from 2001 until December 2012 were considered for inclusion in this review. 
Methodological quality 
The studies were independently assessed by two reviewers using standardized critical 
appraisal instruments from the Joanna Briggs Institute. 
Data collection 
Quantitative data was extracted from papers included in the review using the standardized data 
extraction tool from the Joanna Briggs Institute, specifically the Meta Analysis of Statistics 
Assessment and Review Instrument (JBI-MAStARI). Economic data was extracted from papers 
included in the review using the standardized data extraction tool from the Joanna Briggs 
Institute Analysis of Cost, Technology and Utilisation Assessment and Review Instrument 
(JBI-ACTUARI). 
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Data synthesis 
This review set out to conduct both meta-analyses of the findings of effectiveness studies using 
JBI-MAStARI and pooling of economic findings using JBI-ACTUARI. Because of the number of 
studies found, this was not possible and the findings are therefore presented in tabular or 
narrative form. 
Results 
The quantitative component of the review identified two RCTs for inclusion with one of the trials 
favoring intravenous iron over oral iron for anemia correction. Only a subgroup could be 
included from the second trial and the results were inconclusive. Data was heterogeneous and 
did not allow a meta-analysis. 
The search for the economic component of the review revealed no examination of the cost 
effectiveness of preoperative correction of iron deficiency anemia with intravenous iron. 
Conclusions 
The review found insufficient data to make firm conclusions about the effectiveness of 
preoperative intravenous iron administration for the correction of anemia. Neither could we 
establish firm conclusions on the potential cost savings due to intravenous iron 
supplementation. 
Keywords 
Preoperative anemia, iron deficiency, intravenous iron, oral iron, blood transfusion, adverse 
effects, cost-benefit, cost-effectiveness 
Background 
Most countries from around the world will be facing significant demographic changes over the next two 
decades. These changes will result in a dramatic increase in the older population and a decrease of the 
young.
1
 The demographic changes will result in more complex surgical procedures in the elderly and 
consequently lead to an increase in demand for blood products and a sharp drop in donations from a 
lack of young donors. This looming shortfall has to be addressed urgently. 
The transfusion of red blood cells (RBC) for the correction of anemia is a widely accepted treatment 
modality and a common occurrence in the perioperative period. In the US, 16 million units of blood are 
collected each year but only 20% of all transfusions are given for hemorrhagic shock to the 
hemodynamically unstable patient and may therefore be potentially lifesaving.
2
 Most RBCs are 
prescribed to stable patients according to empirical guidelines. However, guidelines appear to be 
frequently ignored or underutilized and many clinicians revert to transfusion practices based on 
individual beliefs.
3
 Despite an increasing body of evidence that perioperative allogeneic transfusion 
contributes to negative outcomes, such as increased length of stay (LOS), increased infection rates, 
increased occurrence of transfusion-related lung injury (TRALI), transfusion-related circulatory overload 
(TACO) and the high number of deaths, this form of anemia management continues.
2
 Many of these 
transfusion events can be avoided if more attention is spent on optimizing preoperative hemoglobin 
values and the patients iron status. 
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Iron deficiency anemia (IDA) is a common condition. Age, socioeconomic circumstances, poor nutrition, 
and physiological processes (i.e. pregnancy) can result in anemia.
4
 Many pathological states also 
commonly lead to severe iron depletion. These include inflammatory bowel disease, colorectal cancer 
and menorrhagia. In patients presenting for surgery iron deficiency, with or without anemia, is found in 
up to 75% of non-cardiac surgical patients.
5
 This frequently results in an increased number of cardiac 
complications, days in hospital, allogeneic transfusion events and deaths. A more recent publication 
confirmed the incidence of anemia and stated that even mild forms of anemia increase 30-day 
mortality.
6
 These findings imply that preoperative anemia screening and correction should become an 
integral part of the preoperative assessment and management process. 
In many countries transfusion-related costs are of no consequence to the physician or the patient. In 
some countries like Australia, these costs are not even of any consequence for the hospital. This 
situation does not provide a platform for initiatives to facilitate change. 
Patients from these high risk groups should be assessed, ideally at least four weeks prior to major 
surgery particularly. This would allow clinicians to interpret blood results with a window of opportunity to 
act. If the surgery is not urgent a delay should also be considered to investigate the cause of the 
anemia. In the common occurrence of iron deficiency anemia, there is increasing evidence that in 
urgent cases a more contemporary approach with intravenous iron might benefit the patient.
7
 
The economic benefits of preoperative anemia correction are difficult to assess. Cost of transfusion and 
transfusion-related morbidity has to be balanced against the cost of robust preoperative anemia 
management. The Canadian Ontario Transfusion Coordinators (ONTraC) program placed a network of 
nurse transfusion coordinators in 23 hospitals. These hospitals accounted for 65% of allogeneic red 
blood cell transfusions. Most hospitals reduced their red cell consumption significantly allowing for 
estimated potential annual cost savings of 14.6 million Canadian dollars.
8
 
A preliminary search of MEDLINE, The Cochrane Library, Embase, and Health Business Elite found no 
existing systematic reviews of effectiveness evidence and economic evidence on intravenous iron 
administration on the correction of iron deficiency anemia in the preoperative period. 
Therefore this systematic review will aim to critically appraise, synthesize and present the best available 
evidence related to the effectiveness and economic cost-benefit ratio of intravenous iron administration 
on the correction of preoperative iron deficiency anemia. 
Objectives 
The quantitative objective is to identify the effectiveness of intravenous iron administration on the 
correction of iron deficiency anemia in the preoperative period. 
More specifically, the objectives are to identify the effectiveness of iron infusion on the rate of RBC 
transfusion, the incidence of transfusion-related comorbidities such as postoperative infection, 
immunological morbidity and mortality, as well as changes in functional capacity that could impact on 
quality of life. 
The economic objective of this review is to identify the cost aspects of anemia management. 
JBI Database of Systematic Reviews & Implementation Reports  2013;11(10) 157 - 189 
 
Frossler et al Preoperative anemia management with intravenous iron: a systematic review. © the authors 2013    
doi: 10.11124/jbisrir-2013-1010        Page 161 
More specifically, the objectives are to identify the evidence of cost benefits on preoperative anemia 
correction and the potential for cost savings on blood products and indirect cost savings on transfusion 
related adverse effects.  
Inclusion criteria 
Types of participants 
The quantitative component and also the economic component of the review considered studies that 
included adult patients older than18years presenting for major surgery, regardless of gender, ethnicity, 
diagnosis and co-morbidities with preoperative anemia. 
Types of intervention(s)/phenomena of interest 
The quantitative component of the review  considered studies that evaluated the management of 
anemia with iron infusions compared to oral iron treatment alone, oral iron in combination with 
erythropoietin, erythropoietin alone, or hemoglobin correction with blood transfusion. This included the 
dosage of iron, the frequency of its administration and the timeframe of treatment prior to surgery. In 
addition, it also assessed how intervention was employed, the personnel involved and the time spent to 
complete management. 
The economic component of this review considered studies that evaluated the costs and benefits (cost- 
effectiveness, cost-utility, or cost-benefit) of iron infusions compared to oral iron treatment or 
hemoglobin correction with blood transfusion for the treatment of preoperative anemia. 
Types of studies 
The quantitative component of the review considered any experimental study design, including RCTs, 
non-RCTs, quasi-experimental, and before and after studies, for inclusion. 
The economic component of the review considered cost effectiveness, cost-utility, and cost-benefit 
studies for inclusion. 
Types of outcomes 
The quantitative component of this review considered studies that included (but was not limited to) the 
following outcome measures: 
• Effect of iron administration on hemoglobin levels 
• Rate of RBC transfusion measured as proportion of patients transfused with allogeneic RBC and the 
average number of units transfused 
• Length of stay in hospital 
• Rate of readmission within 30 days of discharge 
• Incidence of transfusion related co-morbidities measured as infection rates, occurrence of transfusion 
related lung injury (TRALI), transfusion related circulatory overload (TACO), and number of deaths. 
• Impact of intravenous iron administration on functional outcomes. 
The economic component of the review considered (but was not limited to) the following outcome 
measures: 
• Reduction in costs for units of allogeneic blood avoided 
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• Reduction in costs associated with a reduction in length of stay in hospital 
• Reduction in transfusion laboratory costs and nursing time 
• Increase in costs for iron administered and nursing time. 
Search strategy 
The search strategy aimed to find both published and unpublished studies. A three-step search strategy 
was utilized in this review. An initial limited search of MEDLINE was undertaken followed by an analysis 
of the text words contained in the title and abstract, and of the index terms used to describe the articles. 
A second search using all identified keywords and index terms was then undertaken across all included 
databases. Next, the reference list of all identified reports and articles was searched for additional 
studies. Studies published in English, German, Italian and Dutch were considered for inclusion in this 
review. Awareness of transfusion and anemia related outcomes have been addressed over the last 10 
years. Therefore studies published from 2001 to December 2012 were considered for inclusion in this 
review. 
The databases searched included: 
• PubMed 
• EMBASE 
• The Cochrane Library 
• Health Business Elite database 
• NHS Economic Evaluation Database (NHS EED) 
• Health Economic Evaluation Database (HEED). 
The search for unpublished studies included: MedNar and ProQuest Dissertation and Thesis. 
Method of the review 
Quantitative papers selected for retrieval was assessed by two independent reviewers for 
methodological validity prior to inclusion in the review using standardized critical appraisal instruments 
from the Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instrument 
(JBI-MAStARI) (Appendix V). Any disagreements that arose between the reviewers was resolved 
through discussion, or with a third reviewer. 
Economic papers selected for retrieval were assessed by two independent reviewers for 
methodological validity prior to inclusion in the review using standardized critical appraisal instruments 
from the Joanna Briggs Institute Analysis of Cost, Technology and Utilization Assessment and Review 
Instrument (JBI-ACTUARI) (Appendix V). Any disagreements that arose between the reviewers were 
resolved through discussion, or with a third reviewer. 
Data collection 
Quantitative data was extracted from papers included in the review using the standardized data 
extraction tool from JBI-MAStARI (Appendix VI). The data extracted included specific details about the 
interventions, populations, study methods and outcomes of significance to the review question and 
specific objectives. 
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Economic data was extracted from papers included in the review using the standardized data extraction 
tool from JBI-ACTUARI (Appendix VI). The data extracted included specific details about the 
interventions, populations, study methods and outcomes of significance to the review question and 
specific objectives. 
Data synthesis 
Quantitative papers was, where possible, pooled in statistical meta-analysis using JBI-MAStARI. All 
results were subject to double data entry. Effect sizes expressed as odds ratio (for categorical data) and 
weighted mean differences (for continuous data) and their 95% confidence intervals were calculated for 
analysis. Heterogeneity was assessed statistically using the standard Chi-square. Where statistical 
pooling was not possible the findings were presented in narrative form including tables and figures to 
aid in data presentation where appropriate. 
Quantitative papers were, where possible, pooled in statistical meta-analysis using JBI-MAStARI. All 
results were subject to double data entry. Effect sizes expressed as odds ratio (for categorical data) and 
weighted mean differences (for continuous data) and their 95% confidence intervals were calculated for 
analysis. Heterogeneity was assessed statistically using the standard Chi-square. Where statistical 
pooling was not possible the findings were presented in narrative form including tables and figures to 
aid in data presentation where appropriate. 
Economic findings were, where possible, pooled using JBI-ACTUARI and presented in a tabular 
summary. Where this was not possible, findings were presented in narrative form. 
Results 
Description of studies 
Seventy-nine potentially relevant papers were identified in database searches. Titles and abstracts 
were examined for 63 papers. Three full text papers were retrieved for comprehensive examination. 
One paper was excluded after full text examination and two studies were selected for critical appraisal 
(Figure 1). On final assessment, two studies were identified as fulfilling all of the criteria for inclusion. 
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Figure 1: Identification and selection of studies 
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The first included study by Kim et al. was an open-label, prospective, randomized, multicenter trial 
conducted at three hospitals (including a tertiary referral center) in Seoul, Korea.
9
 Patients enrolled 
were women with menorrhagia, where the condition resulted in IDA and hemoglobin levels of <9 g/dl. 
Patients were randomized to receive either intravenous iron sucrose or oral iron protein succinylate, 
starting three weeks prior to scheduled surgery. Based on a two-tailed α of 0.05, it was determined that 
36 patients per group were required to detect a 1-g/dl Hb difference in the primary outcome variable with 
a power of 80%.  
No severe adverse effects were observed in the study period. Seventy-six patients were randomized 
and 30 completed the study in the intravenous iron arm and 26 in the oral arm. Thirty (76.7%) patients 
reached the target Hb in the intravenous iron group compared with 20 (11.5%) in the oral iron group RR, 
95% CI (p< 0.0001). Hb and ferritin were also significantly higher in the intravenous group at the end of 
the study. The intravenous iron group had a greater increase in the Hb level than the oral iron group (3.0 
vs. 0.8 g/dl, respectively; p < 0.0001) associated with an increase in the ferritin level (170.1 vs. 4.1 µg/l; 
p < 0.0001). This was a well-conducted study in a patient cohort with significant iron deficiency anemia. 
The other phenomena of interest for this review, the rate of RBC transfusion, the average number of 
units transfused, the length of stay in hospital, the rate of readmission within 30 days of discharge, the 
incidence of transfusion related co- morbidities, the number of deaths and the impact of intravenous iron 
administration on functional outcomes, were not reported in this study. 
The second (partially) included study by Edwards et al. was a single-center study in patients with 
suspected bowel cancer scheduled to undergo a bowel resection.
10
 The study was powered at 80% to 
detect a 0.5 g/dl hemoglobin change between recruitment and the day of admission. In addition the 
hemoglobin value on the day of hospital discharge was recorded. All patients of a particular period, 
fulfilling the inclusion criteria, were enrolled and allocated to a treatment (intravenous iron) group or a 
placebo group. No significant difference was found for the primary outcome parameter between the 
groups and mean changes in hemoglobin value between recruitment and at presentation for surgery 
were -019 g/dl for the intravenous iron group and -0.50 g/dl for the placebo group. IQR, 95%CI 
(p=0.355).  
Only 18 subjects (nine in each arm) out of a total of 62 participants were anemic. The subgroup results 
could be included in this review, as the patients demonstrated the inclusion criteria for this review. The 
analysis of the anemic subgroup did not show any outcome differences. Mean change from recruitment 
to preoperative values were −0.46 g/dl (−0.79, −0.12) in the intravenous iron group compared with 
−0.11 g/dl (−0.63, 0.41) in the placebo group (p=0.223). There was no separate analysis or reporting of 
the discharge hemoglobin in the anemic subgroup. In addition, no differences were demonstrated in any 
of the secondary outcome measures hematocrit, mean cell Hb (MCH), reticulocytes, serum iron, ferritin 
and transferrin saturation.  
The other phenomena of interest for this review − the rate of RBC transfusion, the average number of 
units transfused, the length of stay in hospital, the rate of readmission within 30 days of discharge, the 
incidence of transfusion related co-morbidities, the number of deaths and the impact of intravenous iron 
administration on functional outcomes − were not reported in this study. 
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Discussion 
The burden of anemia 
As the most common global nutritional deficiency, the burden on society resulting from anemia is 
immense. Anemia-related symptoms such as fatigue, impaired cognitive function and poor exercise 
tolerance lessen quality of life that leads to huge productivity losses.
11
 
The prevalence of IDA varies, depending on sources, definitions and patient cohorts.
12,13
 Iron 
deficiency, with or without anemia, is found in up to 75% of patients presenting for surgery.
14
 A growing 
body of evidence suggests that this has serious consequences for the perioperative period. IDA 
frequently leads to an increased number of cardiac complications, an increased number of days in 
hospital and a greater number of allogeneic transfusion events.
3
 Preoperative anemia was also shown 
to independently increase perioperative mortality.
5
 A more recent publication involving 227,425 
patients, of whom 69,229 (30.44%) had preoperative anemia, confirmed the high incidence and 
concluded that even mild forms of anemia increase 30-day mortality.
6
 
Anemia is commonly aggravated in the postoperative period. Intraoperative blood loss, wound 
drainage, hemodilution and frequent venipuncture for testing are all contributing factors. In addition, 




Impact on blood usage and utilization 
When it comes to the surgical setting, which is the particular focus of this review, the presence of 
anemia often results in RBC transfusion. This continues to be a widely accepted treatment modality 
despite the clear and well described potential adverse effects and outcomes.
16
 Donated blood is often 
claimed and perceived to be “safe”, prompting many clinicians to transfuse as a default position. Old 
dogmas prevail and the decision to transfuse is not only taken lightly but also often triggers a minimum 
transfusion of two units.
17
 This is especially important as there appears to be a significant dose 
dependent effect of transfusion related adverse effects. It needs to be emphasized that not only total 




By donating blood, donors place a valuable resource into the clinicians’ hands with the assumption that 
it will be dealt with responsibly. This responsibility should be taken into account each time blood 
products are prescribed. It can however be noted that prescribing a blood transfusion is a process which 
remains too easy, is rarely discussed and often left to the inexperienced medical officer.
19
 A common 
lack of documentation and/or consent accentuates the lack of scrutiny applied to the process of 
transfusion. The transfusion event is poorly monitored, is often inappropriate, unjustified and, due to 
various different funding models, sometimes comes at no cost for the health care provider (i.e. 
Australia).
20
 These factors combined make it unlikely that clinical practice will change. 
Risk groups and identification 
This review highlights that many patients who present for surgery are at risk of iron deficiency. This 
subsequently exposes them to a number of potential complications and a higher transfusion risks. This 
risk increases with the type and extent of the surgery, but also with the underlying disease process.
21
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Certain types of patients stand out and should make the clinician cautious. Patients with 
gastro-intestinal malignancies show the highest prevalence of IDA.
5
 Chronic and longstanding blood 
loss results in iron loss and iron store depletion. Inflammatory bowel disease exposes patients to similar 
risks.
22
 Women with menorrhagia often suffer from heavy menstrual bleeding for many years leading to 
gradual iron depletion. In these, generally otherwise healthy women, the condition is often well tolerated 
for a very long time and women frequently present with severe IDA to emergency departments when the 
tipping point is reached (personal observation). Patients scheduled for cardiac or orthopedic surgeries 
commonly combine many disadvantages. Advanced age, significant comorbidities such as congestive 
heart failure, ischemic heart disease, osteoarthritis and renal disease often compound the problem and 
ID and IDA becomes multifactorial.
23
 An inflammatory state as a result of the chronic disease process 
leads to hepcidin increases and down regulation of iron absorption and utilization.
24
 Certain medication 
may also further impair absorption (i.e. proton pump inhibitors, antacids) and other drugs can contribute 
to blood loss (aspirin, clopidogrel, warfarin, NSAIDs) threatening iron metabolism and iron balance.
25, 26
 
As many of the described findings are treatable and/or preventable it is obvious that preoperative 
anemia screening, detection and correction, particularly in patient groups at risk of IDA, should become 
an integral part of the preoperative assessment and management process. Iron deficiency with or 
without anemia is not a physiological state. It must therefore be considered a “disease process”. In 
medical practice we are required to treat disease and as such, anemia correction deserves much more 
attention. This makes it all the more surprising that our study found such a limited numbers of related 
studies. 
Approach to change 
It is clear, however, that high level evidence alone will not guarantee knowledge translation. Conducting 
audits and providing feedback can be a powerful intervention and provide the adequate tool in achieving 




 This was reiterated very recently by a panel of experts at the 
International Consensus Conference on Transfusion and Outcomes held in April 2009 in Phoenix.
28
 The 
panel concluded that there is little evidence to support a beneficial effect from the greatest number of 
transfusions currently being given to patients. 
Experts and authorities from around the world, including the World Health Organization, have 
recognized the need for change and the importance of more appropriate treatment approaches.
29,30
 
This can be facilitated through the implementation of Patient Blood Management (PBM) programs. It is 
crucial, however, that awareness is created and that PBM programs are driven by a local team 
underpinned by government support. Recognizing the importance of such change, accreditation, 
education and audit should consequently be linked in with PBM, and be compulsory. Even short 
educational sessions improved transfusion practice in the perioperative setting.
31
 Physicians who 
understand transfusion indications and are receptive to input from colleagues apply a significantly 
higher quality transfusion practice.
32
 Education, therefore, in addition to a willingness to accept “expert 
advice” is fundamental. 
Models of practice 
Pregnancy is one of the key areas where this has been explored. Pregnant women are a 
well-recognized risk group for developing ID and IDA. In the context of this review, the existing evidence 
from this patient cohort could not be included because the condition is not considered “preoperative” per 
se. However, 30% of women deliver by caesarean section, a surgical procedure with an average blood 
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loss of 400 ml. In addition to this, even normal vaginal delivery is often associated with significant blood 
loss. 
Several studies have shown significant benefits from the administration of intravenous iron compared to 
oral iron supplementation.
13,33
 Changes in Hb allowed women to be better prepared for delivery. This 
also enabled women to tolerate and recover better from blood loss associated with labor, which in 13% 
of women is moderate to severe.
12
 Restoration of iron stores often alleviates ID-associated symptoms. 
These benefits are also felt in the post-partum period by reducing the incidence of post-partum 
depression and prolonging breast feeding episodes.
13,34
 Therefore, despite the lack of evidence in the 
“surgical” population, some of the results from obstetric patients can offer insight and may be translated. 
Interim solutions 
In the absence of multiple RCTs in the literature providing guidance, one has to appreciate that 
prospective and retrospective cohort studies have described intravenous iron as an effective 
intervention.
35-37
 Due to a high risk of serious adverse events associated with infusions of iron dextran, 
physicians have been cautious about intravenous intervention and have frequently substituted it with 
the transfusion of RBCs to correct any preoperative anemia.
38
 In some clinical settings, however, it has 
been demonstrated that intravenous iron appears to be beneficial, particularly in iron deficient patients, 
with or without anemia.
37,39
 Newer types of low molecular weight intravenous irons offer a much 
improved safety profile resulting in significantly lower incidences of adverse effects.
40
 In recent years, 
this has led to the expansion of licensed indications for iron sucrose and ferric carboxymaltose, for 
example. It is surprising therefore that this treatment has not been studied extensively and there is not 
enough data from RCTs to support this approach. Accumulating observational data appears promising 
but randomized trials are needed to evaluate efficacy and cost effectiveness. In addition to dose 
requirements, trials are needed to determine the ideal time of administration and to identify the patient 
groups most in need of this intervention. 
The majority of surgery is undertaken in an elective setting. Clinicians should strive for optimal patient 
outcomes in an attempt to minimize morbidity and mortality.
4
 The development of patient blood 
management guidelines should assist in addressing anemia in order to minimize patient exposure to 
allogeneic blood, to enhance patient recovery and contribute to overall cost savings within health 
sectors, already under enormous financial strain.
41
 Divided into three pillars, reflecting the pre-, intra- 
and post-operative phase, the preoperative period should focus on the detection and correction of 
anemia and iron deficiency. One could argue that no patient with anemia booked for elective surgery 
should enter the operating room. It is however crucial to identify patients with the appropriate test, 
communicate this well amongst involved specialties, and decide on the right strategy and treatment 




The search for the economic component of the review revealed no RCTs examining the cost 
effectiveness of the preoperative correction of iron deficiency anemia with iv iron. Considering the 
enormous health care expenditure for the provision of blood and blood products this is another 
interesting finding. In Australia for example the total cost to government to cover the demands for these 
products reached almost a total of $1 billion in 2010/11.
20
 In many instances, transfusion of RBCs 
remains the default position for the correction of preoperative anemia. As mentioned above, the risks of 
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transfusions are well demonstrated and acknowledged. Murphy established a direct link between 
transfusion of patients undergoing cardiac surgery and infection rates. Transfusion avoidance by 
anemia correction could have resulted in a 40% overall reduction in hospital cost.
42
 The rising costs and 
looming shortage and availability of RBCs add to the multiple disadvantages of allogeneic transfusions. 
Analyzing the cost of transfusion in the surgical setting should involve all steps required at a hospital 
level, called activity based cost. This is crucial in order to reflect the true cost of blood but is very 
complex. Due to fundamental differences in health jurisdictions, these cost factors are not universally 
applicable, but it is possible to establish identifying principles. Irrespective of the health system 
examined, it is highly likely that the real cost of blood has been underestimated in the past.
43
 Many 
jurisdictions are already employing implementation of tools that identify activity for blood usage and this 
will certainly assist in rigorous cost analysis. 
Blood management has been on the agenda for some time. It is therefore surprising that, despite a vast 
amount of publications and multiple guidelines available, knowledge translation is lacking and many 
transfusion events remain inappropriate. 
Unmanaged anemia leads to a significant increase in transfusion. A Canadian program demonstrated 
successfully improved clinical outcomes and cost savings by managing patients appropriately in the 
preoperative period.
3
 A recent publication on the implementation of a local blood management 
algorithm in major orthopedic surgery illustrated that cost-savings can be achieved.
44
 In a RCT setting 
oral iron supplementation has been shown to reduce transfusion incidence resulting in significant cost 
savings. 
46,45
 Depending on the time frame prior to surgery and the severity of the anemia and/or iron 
depletion, intravenous iron administration appears to be an even more effective approach.
35,37,46
 
It is important to remember that the main target of patient care is patient outcome. Patient blood 
management should be standard care for all patients in the surgical setting. Even if total transfusion 
avoidance is not feasible for all patients, overall reductions are achievable. Endorsing appropriate 
transfusion approaches in combination with preoperative optimization should result in improved patient 
well-being, and cost savings are likely to be a logical flow on effect. 
Conclusion 
There is a significant gap in the literature. Our study found insufficient data to make firm conclusions 
about the efficacy of preoperative intravenous iron administration for the correction of anemia based on 
clinical trial settings. Neither could we establish firm conclusions on the potential cost savings due to 
intravenous iron supplementation 
Implications for practice 
There is inadequate RCT evidence at present to guide clinical practice. 
Implications for research 
An adequately powered RCT is needed to determine whether anemia can be adequately corrected and 
is cost effective when preoperative intravenous iron is administered. 
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Appendix I: Search strategy 
PubMed 
("surgical procedures, operative"[MeSH Terms] AND "preoperative care"[MeSH Terms]) AND 
("iron/deficiency"[MeSH Terms] OR "anemia"[MeSH Terms] OR "anemia, iron-deficiency"[MeSH 
Terms]) AND ("blood transfusion"[MeSH Terms] OR ("hematinics/administration and dosage"[MeSH 
Terms] OR "hematinics/therapeutic use"[MeSH Terms]) OR ("erythropoietin/administration and 
dosage"[MeSH Terms] OR "erythropoietin/therapeutic use"[MeSH Terms]) OR ("iron/administration 
and dosage"[MeSH Terms] OR "iron/therapeutic use"[MeSH Terms]) OR ("iron 
compounds/administration and dosage"[MeSH Terms] OR "iron compounds/therapeutic use"[MeSH 
Terms]) OR ("infusions, intravenous"[MeSH Terms] AND "iron"[MeSH Terms])) AND 
("2003/02/14"[PDat] : "2013/02/10"[PDat] AND English[lang])("surgical procedures, operative"[MeSH 
Terms] AND "preoperative care"[MeSH Terms]) AND ("iron/deficiency"[MeSH Terms] OR 
"anemia"[MeSH Terms] OR "anemia, iron-deficiency"[MeSH Terms]) AND ("blood transfusion"[MeSH 
Terms] OR ("hematinics/administration and dosage"[MeSH Terms] OR "hematinics/therapeutic 
use"[MeSH Terms]) OR ("erythropoietin/administration and dosage"[MeSH Terms] OR 
"erythropoietin/therapeutic use"[MeSH Terms]) OR ("iron/administration and dosage"[MeSH Terms] 
OR "iron/therapeutic use"[MeSH Terms]) OR ("iron compounds/administration and dosage"[MeSH 
Terms] OR "iron compounds/therapeutic use"[MeSH Terms]) OR ("infusions, intravenous"[MeSH 
Terms] AND "iron"[MeSH Terms])) AND ("2003/02/14"[PDat] : "2013/02/10"[PDat] AND English[lang]) 
Database: Embase<1980 to 2012 Week 35> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1 exp Surgical Procedures, Operative/ (2924635) 
2 exp Preoperative Care/ (32993) 
3 Iron deficiency/ (7861) 
4 anemia/ (94470) 
5 Anemia, Iron-Deficiency/ (11933) 
6 exp Blood Transfusion/ or Hematinics/ad, tu [Administration & Dosage, Therapeutic Use] (110562) 
7 Erythropoietin/ad, tu [Administration & Dosage, Therapeutic Use] (655) 
8 Iron/ad, tu [Administration & Dosage, Therapeutic Use] (1851) 
9 exp Iron Compounds/ad, tu [Administration & Dosage, Therapeutic Use] (77) 
10 Infusions, Intravenous/ (310622) 
11 Iron/ (98811) 
12 anemia/dm, dt, pc, rh, th [Disease Management, Drug Therapy, Prevention, Rehabilitation, Therapy] 
(18509) 
13 iron deficiency anemia/dm, dt, pc, rh, th [Disease Management, Drug Therapy, Prevention, 
Rehabilitation, Therapy] (5041) 
14 1 and 2 (32993) 
15 3 or 4 or 5 (109211) 
16 10 and 11 (1175) 
17 6 or 7 or 8 or 9 or 16 (113583) 
18 14 and 15 and 17 (120) 
19 12 or 13 (23150) 
20 14 and 19 (134) 
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21 18 or 20 (166) 
22 exp "Costs and Cost Analysis"/ (225568) 
23 economics.mp. or economics/ (242587) 
24 22 or 23 (420714) 
25 21 and 24 (15) 
26 limit 21 to (evidence based medicine or concensus development or meta analysis or outcomes 
research or "systematic review") (5) 
27 limit 21 to (clinical trial or RCT or controlled clinical trial or multicenter study or phase 1 clinical trial or 
phase 2 clinical trial or phase 3 clinical trial or phase 4 clinical trial) (44) 
28 26 or 27 (46) 
ACTUARI 
PubMed 
("economics"[MeSH Subheading] OR "costs and cost analysis"[MeSH Terms] AND 
("2003/02/14"[PDat] : "2013/02/10"[PDat] AND English[lang])) AND (("surgical procedures, 
operative"[MeSH Terms] AND "preoperative care"[MeSH Terms]) AND ("iron/deficiency"[MeSH Terms] 
OR "anemia"[MeSH Terms] OR "anemia, iron-deficiency"[MeSH Terms]) AND ("blood 
transfusion"[MeSH Terms] OR ("hematinics/administration and dosage"[MeSH Terms] OR 
"hematinics/therapeutic use"[MeSH Terms]) OR ("erythropoietin/administration and dosage"[MeSH 
Terms] OR "erythropoietin/therapeutic use"[MeSH Terms]) OR ("iron/administration and 
dosage"[MeSH Terms] OR "iron/therapeutic use"[MeSH Terms]) OR ("iron compounds/administration 
and dosage"[MeSH Terms] OR "iron compounds/therapeutic use"[MeSH Terms]) OR ("infusions, 
intravenous"[MeSH Terms] AND "iron"[MeSH Terms])) AND ("2003/02/14"[PDat] : "2013/02/10"[PDat] 
AND English[lang])) AND ("2003/02/14"[PDat] : "2013/02/10"[PDat] AND English[lang]) 
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Appendix V: Appraisal instruments 
MAStARI appraisal instrument 
this is a test message 
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ACTUARI appraisal instrument 
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Appendix VI: Data extraction instruments 
MAStARI data extraction instrument 
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ACTUARI data extraction instrument 
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Appendix VII: Included studies 
MAStARI 
Author/year/country Kim Y H, Chung H H, Kang S B, Kim S C, Kim Y T\2009\Korea 
Study Safety and usefulness of intravenous iron sucrose in the management 
of preoperative anaemia in patients with menorrhagia 
Method RCT 
Participants 76 patients with haemoglobin levels < 9.0 g/dl who were scheduled to 
undergo surgical treatment 
Intervention  Randomized to receive either intravenous iron sucrose or oral iron 
Outcomes To detect a 1-g/dl Hb difference 
adverse effects 
compliance 
Risk of bias/allocation 
concealment 
Premature cessation of the oral iron arm, relatively small number, some 
protocol violations that limited the clinical and laboratory data were 
possible 
Level of evidence II 
Notes Intravenous iron was superior to oral iron in this study. The target 
haemoglobin was achieved in a significantly higher percentage of 
patients after intravenous iron administration. There was also a 
significant difference in the magnitude of haemoglobin increase and the 
ferritin levels in the iv group. No serious adverse events were recorded 
in either group. 
 
 
Author/year/country Edwards T J, Noble, E J, Durran A, Mellor, N, Hosie K B /2009/ UK 
Study RCT of preoperative intravenous iron sucrose to reduce blood 
transfusion in anaemic patients after colorectal cancer surgery 
Method RCT, prospective, blinded, placebo-controlled 
Participants 62 adult patients to undergo bowel resection for suspected colorectal 
cancer   
Intervention  Intravenous placebo vs intravenous iron sucrose 
Outcomes The primary outcome measure was change in Hb concentration 
between recruitment and day of admission. 
Secondary outcomes were transfusion rate, changes in serum iron 
markers over the same time period, length of hospital stay and 
adverse perioperative events. 
Risk of bias/allocation Excluding patients with previous transfusion and on oral iron, patients 
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concealment with potential profound anaemia, majority of patients randomised 
were not iron deficient or anaemic 
Level of evidence II 
Notes Only 9/34 patients with anaemia in the intravenous group and 9/26 
patients with anaemia in the oral group. This allows the assumption 
that in most cases treatment with iron was not going to be successful, 
irrelevant of the route of administration  
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Appendix VIII: Excluded studies 
 
Author/year/country Garrido-Martin, P, Nassar-Mansur, M I, de la Llana-Ducros, R, 
Virgos-Aller, T M, Fortunez, P M, Avalos-Pinto, R, Jimenez-Sosa, 
A, Martinez-Sanz, R /2012/ Spain 
Study The effect of intravenous and oral iron administration on 
perioperative anaemia and transfusion requirements in patients 
undergoing elective cardiac surgery: a randomized clinical trial 
Method RCT, prospective, double-blind, placebo-controlled, observational 
clinical trial 
Participants 159 adult patients presenting for cardiac surgery 
Intervention  Three groups, all treated pre-and postoperatively 
Group I intravenous iron sucrose. GII oral iron. GIII placebo 
Outcomes Increase in haemoglobin: transfusion requirements 
Risk of bias/allocation 
concealment 
Study underpowered to show a difference, patient selection 
included all patients in the study period irrespective of the iron 
status 
Level of evidence II 
Notes There is no information on the number of patients with iron 
deficiency or anaemia 
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Appendix IX: List of study findings/conclusions 
 
There is a significant gap in the literature. Our study found insufficient data to make firm conclusions 
about the efficacy of preoperative intravenous iron administration for the correction of anemia based on 
clinical trial settings. We were also unable to establish firm conclusions in respect to the potential cost 
savings due to intravenous iron supplementation. 
 
Aside from the risk posed to the individual patient, continuation of commonly observed transfusion 
practices will result in significant consequences to our health system as a whole. To accommodate the 
future challenges, prevention – by improving and preserving the patient’s red cell mass and thereby 
reducing the number of allogeneic red cell transfusions – must be an important goal. Anemia 
management is at the core of this approach. 
 
 
 
 
 
